Sign in
NVIV Stock Price, Chart, Stats & News
InVivo Therapeutics Holdings Corporation
Save
InVivo Therapeutics Holdings Corporation (NVIV) does not currently pay a dividend.
995,918
Market cap
–
Current P/E
–
Forward P/E
NVIV chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -54.08% |
ROE | -60.12% |
D/E | 0.06x |
Interest coverage ratio | -70.53x |
NVIV valuation
P/E | – |
P/S | – |
P/B | 0.03x |
P/CF | -0.05x |
P/FCF | -0.09x |
P/OCF | -0.05x |
PEG | -0.00x |
EV multiple | -1.66x |
About
InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovative biopolymer scaffolding devices designed to address spinal cord injuries (SCI). Its primary investigational product is the Neuro-Spinal Scaffold implant, a bioresorbable polymer scaffold.
Similar securities
Based on sector and market capitalization
Report issue